Cancer registrations in UK polyurethane foam workers (5511 men, 2315 women), 1971–94
| Males | Females | ||||||
|---|---|---|---|---|---|---|---|
| Obs | Exp | SRR (95% CI) | Obs | Exp | SRR (95% CI) | ||
| *p<0.05, ***p<0.001. | |||||||
| †Excluding other skin (ICD-9 173). | |||||||
| Lip | 140 | 1 | 0.95 | 105 (3 to 586) | 0 | 0.07 | 0 |
| Tongue | 141 | 0 | 1.88 | 0 | 0 | 0.40 | 0 |
| Salivary gland | 142 | 0 | 0.94 | 0 | 0 | 0.34 | 0 |
| Mouth | 143–145 | 6 | 2.42 | 248 (91 to 540) | 0 | 0.46 | 0 |
| Pharynx | 146–149 | 3 | 3.29 | 91 (19 to 266) | 1 | 0.68 | 147 (4 to 819) |
| Oesophagus | 150 | 10 | 10.56 | 95 (45 to 174) | 2 | 2.22 | 90 (11 to 325) |
| Stomach | 151 | 20 | 25.38 | 79 (48 to 122) | 6 | 4.49 | 134 (49 to 291) |
| Small intestine | 152 | 0 | 0.85 | 0 | 0 | 0.28 | 0 |
| Large intestine | 153 | 27 | 26.84 | 101 (66 to 146) | 12 | 10.61 | 113 (58 to 198) |
| Rectum | 154 | 17 | 21.90 | 78 (45 to 124) | 5 | 5.68 | 88 (29 to 205) |
| Liver | 155.0,155.1 | 4 | 2.65 | 151 (41 to 386) | 0 | 0.54 | 0 |
| Gallbladder | 156 | 1 | 1.88 | 53 (1 to 296) | 1 | 0.87 | 115 (3 to 640) |
| Pancreas | 157 | 10 | 11.45 | 87 (42 to 161) | 7 | 3.43 | 204 (82 to 420) |
| Peritoneum | 158 | 1 | 0.64 | 156 (4 to 871) | 0 | 0.24 | 0 |
| Other digestive | 159 | 1 | 0.64 | 156 (4 to 871) | 0 | 0.20 | 0 |
| Nose and sinuses | 160 | 0 | 1.04 | 0 | 0 | 0.26 | 0 |
| Larynx | 161 | 10 | 7.23 | 138 (66 to 254) | 3 | 0.60 | 500* (103 to 1461) |
| Lung and bronchus | 162 | 102 | 103.39 | 99 (80 to 120) | 31 | 15.58 | 199*** (135 to 282) |
| Pleura | 163 | 0 | 2.55 | 0 | 0 | 0.22 | 0 |
| Bone | 170 | 0 | 0.90 | 0 | 0 | 0.26 | 0 |
| Connective tissue | 171 | 4 | 2.32 | 172 (47 to 441) | 2 | 0.81 | 247 (30 to 892) |
| Melanoma | 172 | 3 | 5.89 | 51 (11 to 149) | 2 | 4.11 | 49 (6 to 176) |
| Skin, other | 173 | 45 | 57.67 | 78 (57 to 104) | 11 | 17.71 | 62 (31 to 111) |
| Breast | 175 | 3 | 0.81 | 370 (76 to 1082) | 51 | 52.86 | 96 (72 to 127) |
| Cervix | 180 | – | – | – | 10 | 9.97 | 100 (48 to 184) |
| Uterus | 182 | – | – | – | 2 | 6.83 | 29 (4 to 106) |
| Ovary | 183 | – | – | – | 8 | 9.67 | 83 (36 to 163) |
| Other genital | 184, 187 | 3 | 1.41 | 213 (44 to 622) | 1 | 1.31 | 76 (2 to 425) |
| Prostate | 185 | 30 | 30.71 | 98 (66 to 139) | – | – | – |
| Testis | 186 | 4 | 6.26 | 64 (17 to 164) | – | – | – |
| Bladder | 188 | 19 | 28.10 | 68 (41 to 106) | 2 | 3.58 | 56 (7 to 202) |
| Kidney and other urinary | 189 | 8 | 9.87 | 81 (35 to 160) | 4 | 2.04 | 196 (53 to 502) |
| Eye | 190 | 0 | 0.94 | 0 | 1 | 0.36 | 278 (7 to 1548) |
| Brain | 191–192 | 7 | 9.17 | 76 (31 to 157) | 1 | 2.70 | 37 (1 to 206) |
| Thyroid | 193 | 1 | 1.12 | 89 (2 to 497) | 1 | 1.19 | 84 (2 to 468) |
| Other endocrine glands | 194 | 2 | 0.51 | 392 (47 to 1417) | 0 | 0.22 | 0 |
| Secondary and other cancers | 195–199 | 20 | 19.52 | 102 (63 to 158) | 7 | 6.78 | 103 (42 to 213) |
| Hodgkin’s disease | 201 | 2 | 3.95 | 51 (6 to 183) | 0 | 0.97 | 0 |
| Non-Hodgkin’s lymphoma | 200, 202 | 6 | 12.15 | 49 (18 to 107) | 4 | 3.75 | 107 (29 to 273) |
| Multiple myeloma | 203 | 9 | 4.78 | 188 (86 to 357) | 0 | 1.49 | 0 |
| Leukaemia | 204–208 | 7 | 9.30 | 75 (30 to 155) | 3 | 2.65 | 113 (23 to 331) |
| All malignant neoplasms | 140–208† | 342 | 375.12 | 91 (82 to 101) | 168 | 159.69 | 105 (90 to 122) |